| |
| |
|
| Insider
Information: |
Whitley Richard James |
| Relationship: |
|
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
33,758 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,155,698 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
33,758 |
|
|
| Total
Value |
$2,155,698 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
2
|
|
Stock
price went up :
|
1
|
2
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
 -51.0%
|
 285.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Director |
2021-05-06 |
33,058 |
2010-05-06 |
0 |
Premium* |
|
|
Virios Therapeutics, Llc |
VIRI |
|
2022-12-08 |
700 |
2021-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIRI |
Virios Therapeutics, Llc |
|
– • – |
2022-12-08 |
4 |
S |
$0.26 |
$466 |
D/D |
(1,800) |
700 |
0 |
% |
|
| VIRI |
Virios Therapeutics, Llc |
|
– • – |
2022-05-18 |
4 |
B |
$4.53 |
$2,263 |
D/D |
500 |
2,500 |
0.01 |
% |
|
| VIRI |
Virios Therapeutics, Llc |
|
– • – |
2022-01-06 |
4 |
B |
$5.72 |
$10,296 |
D/D |
1,800 |
2,000 |
0.01 |
% |
|
| VIRI |
Virios Therapeutics, Llc |
|
– • – |
2021-12-23 |
4 |
B |
$5.73 |
$1,145 |
D/D |
200 |
200 |
0.01 |
% |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2021-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,936 |
33,058 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2021-05-03 |
4 |
OE |
$20.65 |
$418,722 |
D/D |
20,282 |
51,404 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2021-05-03 |
4 |
S |
$64.57 |
$1,309,655 |
D/D |
(20,282) |
31,122 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2020-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,434 |
31,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2020-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,270 |
29,688 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,283 |
27,418 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-05-01 |
4 |
AS |
$65.02 |
$619,934 |
D/D |
(9,534) |
25,135 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-05-01 |
4 |
OE |
$22.02 |
$209,891 |
D/D |
9,534 |
34,669 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-04-01 |
4 |
OE |
$22.02 |
$209,891 |
D/D |
9,534 |
34,669 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-04-01 |
4 |
AS |
$65.48 |
$624,255 |
D/D |
(9,534) |
25,135 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2016-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,466 |
25,135 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-11-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,050 |
23,669 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-11-24 |
4 |
S |
$106.48 |
$17,995 |
D/D |
(169) |
30,719 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-11-23 |
4 |
S |
$107.18 |
$306,845 |
D/D |
(2,863) |
30,888 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-11-20 |
4 |
S |
$106.99 |
$589,917 |
D/D |
(5,514) |
33,751 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-05-05 |
4 |
OE |
$0.00 |
$426,364 |
D/D |
23,624 |
39,265 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-03-02 |
4 |
AS |
$103.43 |
$517,136 |
D/D |
(5,000) |
15,641 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-03-02 |
4 |
OE |
$26.99 |
$134,950 |
D/D |
5,000 |
20,641 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-02-02 |
4 |
AS |
$105.16 |
$528,358 |
D/D |
(5,000) |
15,641 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-02-02 |
4 |
OE |
$26.99 |
$134,950 |
D/D |
5,000 |
20,641 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-01-02 |
4 |
AS |
$95.04 |
$476,100 |
D/D |
(5,000) |
15,641 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
